Determining the appropriate retatrutide amount is critically essential for seeing optimal benefits. Initially, people typically start with a modest dose of around 2.4 mg, given every week via subcutaneous . This starting quantity is then incrementally boosted every four instances , reaching a maximum amount of 10.8 mg, based on patient response an